| Literature DB >> 24301426 |
Mohamed Arafah1, Ali T Al-Hinai2, Wael Al Mahmeed3, Khalid Al-Rasadi4, Omer Al Tamimi5, Shorook Al Herz6, Faisal Al Anazi7, Khalid Al Nemer8, Othman Metwally9, Akram Alkhadra10, Mohammed Fakhry10, Hossam Elghetany11, Abdel Razak Medani12, Afzal Hussein Yusufali12, Obaid Al Jassim12, Omar Al Hallaq13, Fahad Omar Ahmed S Baslaib14, Mahmoud Alawadhi15, Haitham Amin16, Khamis Al-Hashmi2, Abdullah Shehab17.
Abstract
The Centralized pan-Middle East Survey on the undertreatment of hypercholesterolemia (CEPHEUS) survey evaluated the attainment of low-density lipoprotein cholesterol (LDL-C) goals among patients on lipid-lowering drugs (LLDs) according to the updated National Cholesterol Education Program (NCEP)-Adult Treatment Panel (ATP-III) guideline. The survey was conducted in 6 Arabian Gulf countries. Patients aged ≥18 years on LLDs for at least ≥3 months (stable medication for ≥6 weeks) were recruited. Fasting blood samples were collected at a single visit. In this survey, 5276 (58.2% male) patients were included in the final analysis. The LDL-C goal was attained in 91.1% of low-risk, 52.7% of high-risk, and 32.0% in very-high-risk categories. Goal attainment was directly related to female gender, age<40 years, history of diabetes, and family history of cardiovascular disease. The results of this survey highlight the suboptimal management of hypercholesterolemia across Arabian Gulf countries.Entities:
Keywords: Arabian Gulf countries; cardiovascular; coronary; guidelines; hypercholesterolemia; lipids; low-density lipoprotein
Mesh：
Substances：
Year: 2013 PMID： 24301426 DOI： 10.1177/0003319713512414
Source DB: PubMed Journal: Angiology ISSN： 0003-3197 Impact factor: 3.619